Latest Announcements

Timken India Limited has submitted its unaudited financial results for the quarter and six months ended September 30, 2026, with a net profit after tax of Rs. 2,311.94 and a total comprehensive income of Rs. 2,295.25. The company has paid a final dividend of Rs. 2.50 per equity share.

Aditya Vision Limited has opened five new showrooms, taking its total to 219, marking its presence in Madhya Pradesh and West Bengal, and expanding its customer base and retail network.

Alivus Life Sciences Limited has released its Q2 FY27 investor presentation, highlighting a 16.0% YoY revenue growth, driven by healthy demand across key markets and robust contributions from recent launches. The company reported a gross margin of 64.4%, up 420 bps QoQ and 670 bps YoY, and an EBITDA margin of 41.8%, up 520 bps QoQ and 880 bps YoY.

Alivus Life Sciences Limited has announced its financial results for the second quarter and half-year, ended September 30, 2026, with revenue from operations for Q2FY27 at Rs. 6,820 Mn, a growth of 16.0% YoY, and EBITDA for Q2FY27 stood at Rs. 2,851 Mn, a growth of 47.0% YoY with margins at 41.8%.

Tamilnad Mercantile Bank Limited has informed the Exchange about the transcript of the earnings conference call hosted by the Bank on the Unaudited Financial Results of the Bank for the quarter and half year ended September 30, 2026, which has been made available on the Bank’s website.

Sambhv Steel Tubes Limited has informed the Exchange about Investor Presentation for Q2 & H1FY27 financial performance, highlighting revenue growth of 44%, operating EBITDA growth of 68%, and PAT growth of 104% YoY.

Asset Reconstruction Company (India) Limited has announced its unaudited financial results for the quarter and half year ended September 30, 2026, with a 21% YoY growth in AUM to Rs. 20,274 crore and a 54% YoY increase in PAT to Rs. 290.0 crore.

Clean Science and Technology Limited's wholly-owned subsidiary, Clean Fino-Chem Limited, has successfully completed product trials.

Sanofi India Limited has declared an Interim Dividend of Rs. 75 per equity share for the financial year 2026, with a record date of November 5, 2026, and the dividend to be paid within stipulated timelines. The company has also announced its financial results for the quarter ended September 30, 2026, reporting domestic net sales growth of 2% and total net sales growth of 4% compared to the third quarter of 2025.

Strides Pharma Science Limited has announced its Q2 and H1FY27 earnings, with revenue growing 17% YoY to ₹14,297m and ₹26,951m respectively, driven by Ex-US Markets. EBITDA grew 8% YoY to ₹2,509m and ₹4,807m respectively, despite higher raw material, freight and operating costs. Net Debt increased by ₹2,114m during H1 due to an elongated cash-to-cash cycle and higher inventory holding.

Sanofi India Limited has announced its financial results for the quarter ended September 30, 2026, with a 2% growth in domestic net sales and a 4% growth in total net sales compared to the third quarter of 2025. The company has also declared an interim dividend of Rs. 75 per equity share and fixed November 5, 2026, as the record date for the payment of the dividend.

Sanofi India Limited has announced its Q3 2026 financial results, reporting a 2% growth in domestic net sales and a 4% growth in total net sales compared to the third quarter of 2025. The company's Insulin portfolio delivered a 9% growth in Q3'26, cementing its leadership in the Diabetes Injectable segment with a 55% market share.

Capital Small Finance Bank Limited has announced its unaudited financial results for the quarter and half year ended September 30, 2026, with Gross Advances increasing to ₹9,755 crore, total Deposits rising to ₹10,831 crore, and Profit After Tax standing at ₹45.61 crore.

Capital Small Finance Bank Limited has released its investor presentation for the period ended September 30, 2026, highlighting its unaudited financial results, including a 23.4% YoY growth in loan book, 16.2% YoY growth in deposits, and a 31% YoY growth in profitability.

Steamhouse India Limited has submitted its Investor Presentation for Q2 & H1 FY27, highlighting a strong year-on-year performance despite seasonal moderation, with a 12.06% year-on-year growth in steam supply volumes and a focus on sustaining growth momentum.

Strides Pharma Science Limited has announced its Q2FY27 financial results, with revenue growing 17% YoY to ₹14,297m, driven by Ex-US Markets, and EBITDA up 8% YoY to ₹2,509m, crossing ₹2,500m in a quarter for the first time.

Kajaria Ceramics Limited reported 10% year-to-year volume growth in Q2 FY27, driven by better demand and market share gains. Consolidated revenue grew 24% year-to-year to INR1,468 crores, with EBITDA margin at 19.5%. The company's capacity expansion plans remain on track, and it expects to sustain healthy growth and strengthen its market position.

Afcons Infrastructure Limited has secured two significant engineering, procurement and construction (EPC) contracts in Uttar Pradesh with a combined value of nearly ₹3,469 crore. The projects comprise the development of the Jewar Link Expressway and a key underground section of the Lucknow Metro Phase-1B.

Tata Consumer Products Limited has announced its Q2 FY27 results, with revenue up 14%, EBITDA up 18%, and net profit at INR470 crores, growing 16%. The company's growth businesses, including Sampann and Ready-to-Drink, have shown strong performance, with Sampann up 57% and Ready-to-Drink strongly back on the growth trajectory with 47% growth.

Shalibhadra Finance Limited has announced a reduction in its Incremental Cost of Borrowing, with a decrease of 0.80% in the interest rate/coupon rate over the past 6 months. The company plans to use Listed Non-Convertible Debentures (NCDs) as a means of raising debt in the future and expects further reduction in borrowing rates.